Strengthening Global Health Preparedness: Serum Institute of India Joins CEPI’s Vaccine Manufacturing Network

Why is the Serum Institute of India joining CEPI's network?

To enhance rapid vaccine production and ensure equitable access during global health crises.

What is CEPI's 100 Days Mission?

Developing vaccines within 100 days of identifying a pandemic threat.

How does SII's collaboration support priority pathogens?

By funding and focusing on the development of vaccines against CEPI's identified priority pathogens.

Why is the global manufacturing network crucial?

It strengthens regional resilience and minimizes response times during disease outbreaks.

What challenges and opportunities does the collaboration present?

Challenges include coordination and regulatory approvals; opportunities lie in innovation and global health strategy development.